학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 6건 | 목록 1~10
Academic Journal
Rochate D; Hematology Department, Hospital do Divino Espírito Santo de Ponta Delgada, Ponta Delgada, Portugal.; González-García AM; Neurology Department, University Hospital of Salamanca, Salamanca, Spain.; Santos Marcos C; Hematology Department, University Hospital of Salamanca-IBSAL, Centro de Investigación del Cáncer, Salamanca, Spain.; Pérez-López E; Hematology Department, University Hospital of Salamanca-IBSAL, Centro de Investigación del Cáncer, Salamanca, Spain.; Martín-López ; Hematology Department, University Hospital of Salamanca-IBSAL, Centro de Investigación del Cáncer, Salamanca, Spain.; Alaña M; Neurology Department, University Hospital of Salamanca, Salamanca, Spain.; Martín Martín L; Hematology Department, University Hospital of Salamanca-IBSAL, Centro de Investigación del Cáncer, Salamanca, Spain.; Flow Cytometry Service, University Hospital of Salamanca-IBSAL, Centro de Investigación del Cáncer, Spain.; López Parra M; Hematology Department, University Hospital of Salamanca-IBSAL, Centro de Investigación del Cáncer, Salamanca, Spain.; Sánchez Guijo F; Hematology Department, University Hospital of Salamanca-IBSAL, Centro de Investigación del Cáncer, Salamanca, Spain.; López Corral L; Hematology Department, University Hospital of Salamanca-IBSAL, Centro de Investigación del Cáncer, Salamanca, Spain.
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE
Academic Journal
Iacoboni G; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; Department of Medicine Universitat Autònoma de Barcelona Bellaterra Spain.; Sánchez-Salinas MA; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; Department of Medicine Universitat Autònoma de Barcelona Bellaterra Spain.; Rejeski K; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center of the LMU Munich Munich Germany.; Adult BMT and Cellular Therapy Service Memorial Sloan Kettering Cancer Center New York New York USA.; Martín-López ; Hematology Department Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC Salamanca Spain.; Centro de Investigación del Cáncer-IBMCC Salamanca Spain.; Kwon M; Department of Hematology Hospital General Universitario Gregorio Marañón Madrid Spain.; Gregorio Marañón Health Research Institute (IiSGM) Madrid Spain.; Navarro V; Oncology Data Science (ODySey) Group, Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; Jalowiec KA; Hematology Department University College London Cancer Institute London United Kingdom.; Department of Hematology and Central Hematology Laboratory University Hospital of Bern Bern Switzerland.; Hernani R; Haematology Department Hospital Clínico Universitario Valencia Spain.; INCLIVA Research Institute Valencia Spain.; Reguera-Ortega JL; Hematology Department, Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC Universidad de Sevilla Sevilla Spain.; Gallur L; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; Department of Medicine Universitat Autònoma de Barcelona Bellaterra Spain.; Blumenberg V; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center of the LMU Munich Munich Germany.; Herrero-García M; Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform) University of Salamanca (USAL) Salamanca Spain.; Roddie C; Hematology Department University College London Cancer Institute London United Kingdom.; Benzaquén A; Haematology Department Hospital Clínico Universitario Valencia Spain.; INCLIVA Research Institute Valencia Spain.; Delgado-Serrano J; Hematology Department, Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC Universidad de Sevilla Sevilla Spain.; Bailén R; Department of Hematology Hospital General Universitario Gregorio Marañón Madrid Spain.; Gregorio Marañón Health Research Institute (IiSGM) Madrid Spain.; Carpio C; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; Department of Medicine Universitat Autònoma de Barcelona Bellaterra Spain.; Amat P; Haematology Department Hospital Clínico Universitario Valencia Spain.; INCLIVA Research Institute Valencia Spain.; López-Corral L; Hematology Department Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC Salamanca Spain.; Centro de Investigación del Cáncer-IBMCC Salamanca Spain.; Martín-Martín L; Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform) University of Salamanca (USAL) Salamanca Spain.; Bastos M; Department of Hematology Hospital General Universitario Gregorio Marañón Madrid Spain.; Gregorio Marañón Health Research Institute (IiSGM) Madrid Spain.; Subklewe M; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center of the LMU Munich Munich Germany.; O'Reilly M; Hematology Department University College London Cancer Institute London United Kingdom.; Barba P; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; Department of Medicine Universitat Autònoma de Barcelona Bellaterra Spain.
Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Academic Journal
Iacoboni G; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; Iraola-Truchuelo J; Experimental Hematology Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; O'Reilly M; Department of Hematology University College London Hospitals London UK.; Navarro V; Oncology Data Science (ODySey) Group Vall d´Hebron Institute of Oncology (VHIO) Barcelona Spain.; Menne T; Department of Hematology Freeman Hospital Newcastle UK.; Kwon M; Department of Hematology Hospital General Universitario Gregorio Marañón Madrid Spain.; Martín-López ; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC University of Salamanca Salamanca Spain.; Chaganti S; Department of Hematology Queen Elizabeth Hospital Birmingham UK.; Delgado J; Hematology Department, Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC Universidad de Sevilla Sevilla Spain.; Roddie C; Department of Hematology University College London Hospitals London UK.; Pérez A; Haematology Department, Hospital Clínico Universitario INCLIVA Research Institute Valencia Spain.; Norman J; Department of Hematology Manchester Royal Infirmary Manchester UK.; Guerreiro M; Haematology Department Hospital Universitario La Fe Valencia Spain.; Gibb A; Department of Hematology The Christie Hospital Manchester UK.; Caballero AC; Hematology Department Hospital Universitario Sant Pau Barcelona Spain.; Besley C; Department of Hematology University Hospitals Bristol and Weston Bristol UK.; Martínez-Cibrián N; Hematology Department Hospital Clínic Barcelona Spain.; Mussetti A; Hematology Department, Institut Catala d'Oncologia, Hospital Duran i Reynals, L'Hospitalet De Llobregat, IDIBELL Universitat de Barcelona Barcelona Spain.; Sanderson R; Department of Hematology King's College Hospital London UK.; Luzardo H; Department of Hematology Hospital Universitario de Gran Canaria Doctor Negrín Islas Canarias Spain.; Iyengar S; Department of Hematology Royal Marsden Hospital London UK.; Sánchez JM; Department of Hematology Hospital Universitario 12 de octubre Madrid Spain.; Jones C; Department of Hematology University Hospital of Wales Cardiff UK.; Sancho JM; Hematology Department ICO-IJC Hospital Germans Trias i Pujol Barcelona Spain.; Barba P; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; Latif AL; Department of Hematology Queen Elizabeth II Hospital Glasgow UK.; López-Corral L; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC University of Salamanca Salamanca Spain.; Hernani R; Haematology Department, Hospital Clínico Universitario INCLIVA Research Institute Valencia Spain.; Reguera JL; Hematology Department, Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC Universidad de Sevilla Sevilla Spain.; Sureda A; Hematology Department, Institut Catala d'Oncologia, Hospital Duran i Reynals, L'Hospitalet De Llobregat, IDIBELL Universitat de Barcelona Barcelona Spain.; Garcia-Sancho AM; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC University of Salamanca Salamanca Spain.; Bastos M; Department of Hematology Hospital General Universitario Gregorio Marañón Madrid Spain.; Abrisqueta P; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.; Kuhnl A; Department of Hematology King's College Hospital London UK.
Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Editorial & Opinion
Martín-Martín L; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca, Salamanca, Spain.; Flow Cytometry Service (NUCLEUS), University of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Gutiérrez-Herrero S; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca, Salamanca, Spain.; Flow Cytometry Service (NUCLEUS), University of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Herrero-García M; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca, Salamanca, Spain.; Flow Cytometry Service (NUCLEUS), University of Salamanca, Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Martín García-Sancho A; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Yeguas A; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Martín-López ; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; López-Corral L; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Pérez-López E; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; García-Blázquez M; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Sánchez-Guijo F; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Vidriales MB; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain.; Department of Hematology, University Hospital of Salamanca, Salamanca, Spain.; Gaipa G; Tettamanti Center and Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; Orfao A; Translational and Clinical Research Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC), and University of Salamanca, Salamanca, Spain. orfao@usal.es.; Flow Cytometry Service (NUCLEUS), University of Salamanca, Salamanca, Spain. orfao@usal.es.; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. orfao@usal.es.; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain. orfao@usal.es.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Carlos III Health Institute, Madrid, Spain. orfao@usal.es.
Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Academic Journal
Iacoboni G; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Navarro V; Oncology Data Science (ODySey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Martín-López ; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.; Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain.; Rejeski K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center of the LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany.; Kwon M; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain.; Jalowiec KA; Hematology Department, University College London Cancer Institute, London, United Kingdom.; Department of Hematology and Central Hematology Laboratory, University Hospital of Bern, Bern, Switzerland.; Amat P; Haematology Department, Hospital Clínico Universitario, Valencia, Spain.; INCLIVA Research Institute, Valencia, Spain.; Reguera-Ortega JL; Hematology Department, Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain.; Gallur L; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Blumenberg V; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center of the LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany.; Gutiérrez-Herrero S; Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca, Spain.; Roddie C; Hematology Department, University College London Cancer Institute, London, United Kingdom.; Benzaquén A; Haematology Department, Hospital Clínico Universitario, Valencia, Spain.; INCLIVA Research Institute, Valencia, Spain.; Delgado-Serrano J; Hematology Department, Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain.; Sánchez-Salinas MA; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Bailén R; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain.; Carpio C; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.; López-Corral L; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.; Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain.; Hernani R; Haematology Department, Hospital Clínico Universitario, Valencia, Spain.; INCLIVA Research Institute, Valencia, Spain.; Bastos M; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain.; O'Reilly M; Hematology Department, University College London Cancer Institute, London, United Kingdom.; Martín-Martín L; Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca, Spain.; Subklewe M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Gene Center of the LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany.; Barba P; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Hidalgo Calleja C; Rheumatology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Paseo de San Vicente 58-182, 37007, Salamanca, Spain. chidalgoc15@gmail.com.; Martín Hidalgo D; Family and Community Medicine Training Programme, Hospital Universitario Río Hortega, Valladolid, Spain.; Román Curto C; Dermatology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain.; Vázquez López L; Haematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.; Pérez López E; Haematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.; Cabrero Calvo M; Haematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.; Martín López ; Haematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.; Caballero Barrigón MD; Haematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.; Lopez-Corral L; Haematology Department, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Cancer Research Institute of Salamanca-IBMCC (USAL-CSIC), 37007, Salamanca, Spain.
Publisher: BioMed Central Country of Publication: England NLM ID: 101734172 Publication Model: Electronic Cited Medium: Internet ISSN: 2523-3106 (Electronic) Linking ISSN: 25233106 NLM ISO Abbreviation: Adv Rheumatol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Martín-López AÁ
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어